BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 12163454)

  • 41. Use of a cryptic splice site for the expression of huntingtin interacting protein 1 in select normal and neoplastic tissues.
    Graves CW; Philips ST; Bradley SV; Oravecz-Wilson KI; Li L; Gauvin A; Ross TS
    Cancer Res; 2008 Feb; 68(4):1064-73. PubMed ID: 18281481
    [TBL] [Abstract][Full Text] [Related]  

  • 42. HIP12 is a non-proapoptotic member of a gene family including HIP1, an interacting protein with huntingtin.
    Chopra VS; Metzler M; Rasper DM; Engqvist-Goldstein AE; Singaraja R; Gan L; Fichter KM; McCutcheon K; Drubin D; Nicholson DW; Hayden MR
    Mamm Genome; 2000 Nov; 11(11):1006-15. PubMed ID: 11063258
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mouse models of prostate cancer.
    Sharma P; Schreiber-Agus N
    Oncogene; 1999 Sep; 18(38):5349-55. PubMed ID: 10498888
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hip1-related mutant mice grow and develop normally but have accelerated spinal abnormalities and dwarfism in the absence of HIP1.
    Hyun TS; Li L; Oravecz-Wilson KI; Bradley SV; Provot MM; Munaco AJ; Mizukami IF; Sun H; Ross TS
    Mol Cell Biol; 2004 May; 24(10):4329-40. PubMed ID: 15121852
    [TBL] [Abstract][Full Text] [Related]  

  • 45. HIP1 as a marker of aggressive prostate cancer.
    Chan EY
    Clin Genet; 2002 Nov; 62(5):372-5. PubMed ID: 12431251
    [No Abstract]   [Full Text] [Related]  

  • 46. Crystal structure at 2.8 A of the DLLRKN-containing coiled-coil domain of huntingtin-interacting protein 1 (HIP1) reveals a surface suitable for clathrin light chain binding.
    Ybe JA; Mishra S; Helms S; Nix J
    J Mol Biol; 2007 Mar; 367(1):8-15. PubMed ID: 17257618
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Actin binding by Hip1 (huntingtin-interacting protein 1) and Hip1R (Hip1-related protein) is regulated by clathrin light chain.
    Wilbur JD; Chen CY; Manalo V; Hwang PK; Fletterick RJ; Brodsky FM
    J Biol Chem; 2008 Nov; 283(47):32870-9. PubMed ID: 18790740
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Huntingtin interacting protein 1 modulates the transcriptional activity of nuclear hormone receptors.
    Mills IG; Gaughan L; Robson C; Ross T; McCracken S; Kelly J; Neal DE
    J Cell Biol; 2005 Jul; 170(2):191-200. PubMed ID: 16027218
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Degenerative phenotypes caused by the combined deficiency of murine HIP1 and HIP1r are rescued by human HIP1.
    Bradley SV; Hyun TS; Oravecz-Wilson KI; Li L; Waldorff EI; Ermilov AN; Goldstein SA; Zhang CX; Drubin DG; Varela K; Parlow A; Dlugosz AA; Ross TS
    Hum Mol Genet; 2007 Jun; 16(11):1279-92. PubMed ID: 17452370
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Deficiency of the Endocytic Protein Hip1 Leads to Decreased
    Wijayatunge R; Holmstrom SR; Foley SB; Mgbemena VE; Bhargava V; Perez GL; McCrum K; Ross TS
    Mol Cell Biol; 2018 Dec; 38(23):. PubMed ID: 30224518
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Models for prostate cancer.
    Prog Clin Biol Res; 1980; 37():1-397. PubMed ID: 7384080
    [No Abstract]   [Full Text] [Related]  

  • 52. Altered fibroblast growth factor receptor 4 stability promotes prostate cancer progression.
    Wang J; Yu W; Cai Y; Ren C; Ittmann MM
    Neoplasia; 2008 Aug; 10(8):847-56. PubMed ID: 18670643
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Two Distantly Spaced Basic Patches in the Flexible Domain of Huntingtin-Interacting Protein 1 (HIP1) Are Essential for the Binding of Clathrin Light Chain.
    Ybe JA; Clegg ME; Illingworth M; Gonzalez C; Niu Q
    Res Lett Biochem; 2009; 2009():256124. PubMed ID: 22820750
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [A new cancer gene--with drama].
    Rehfeld JF
    Ugeskr Laeger; 1994 Feb; 156(6):823-5. PubMed ID: 8016990
    [No Abstract]   [Full Text] [Related]  

  • 55. AZIN1 RNA editing alters protein interactions, leading to nuclear translocation and worse outcomes in prostate cancer.
    Ghalali A; Wang L; Stopsack KH; Rice JM; Wu S; Wu CL; Zetter BR; Rogers MS
    Exp Mol Med; 2022 Oct; 54(10):1713-1726. PubMed ID: 36202978
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Experimental models of prostate cancer research.
    Cohen MB; Padarathsingh M; Hendrix MJ
    Am J Pathol; 2000 Jan; 156(1):355-8. PubMed ID: 10623685
    [No Abstract]   [Full Text] [Related]  

  • 57. Huntingtin interacting protein 1 is a novel brain tumor marker that associates with epidermal growth factor receptor.
    Bradley SV; Holland EC; Liu GY; Thomas D; Hyun TS; Ross TS
    Cancer Res; 2007 Apr; 67(8):3609-15. PubMed ID: 17440072
    [TBL] [Abstract][Full Text] [Related]  

  • 58. HIP1: trafficking roles and regulation of tumorigenesis.
    Hyun TS; Ross TS
    Trends Mol Med; 2004 Apr; 10(4):194-9. PubMed ID: 15059611
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Huntingtin-Interacting Protein-1 Is an Early-Stage Prognostic Biomarker of Lung Adenocarcinoma and Suppresses Metastasis via Akt-mediated Epithelial-Mesenchymal Transition.
    Hsu CY; Lin CH; Jan YH; Su CY; Yao YC; Cheng HC; Hsu TI; Wang PS; Su WP; Yang CJ; Huang MS; Calkins MJ; Hsiao M; Lu PJ
    Am J Respir Crit Care Med; 2016 Apr; 193(8):869-80. PubMed ID: 26595459
    [TBL] [Abstract][Full Text] [Related]  

  • 60. KIF1C and new Huntingtin-interacting protein 1 binding proteins regulate rheumatoid arthritis fibroblast-like synoviocytes' phenotypes.
    Laragione T; Harris C; Gulko PS
    Front Immunol; 2024; 15():1323410. PubMed ID: 38726004
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.